About Orpheus Bioscience

About company

Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases. The company core technology the Pantid is designed to specifically neutralize the pathological component of patient antibody responses and destroy destructive immune cells, without affecting the patient's immune system functionality. This patent includes a novel mechanism of action, targeting autoreactive B cells that specifically react to patient-endogenous proteins, as well as several novel mechanisms for their elimination. Orpheus Bioscience was founded in 2016 and is based in Manassas, Virginia, USA.